| This week's sponsor is FierceBiotech’s Drug Development Forum. | | FierceBiotech’s Drug Development Forum – September 19-21, 2016 Join leading biotech professionals in the first-ever Drug Development Forum in Boston. Discover the latest trends, challenges, and innovations in the biotech industry. Sign up by July 29, 2016 and save $200 on registration.
Register now |
Top Stories Thursday, July 14, 2016 The stock market pullback and lackluster IPO market have weighed on biotech venture financing--but only a bit. The sector is still on track for its second highest venture financing total ever, behind last year’s sums. Friday, July 15, 2016 Despite only being a very small trial and with lingering questions over the primary endpoint, analysts were overall positive on Ultragenyx’s late-stage data for the incredibly rare genetic, metabolic disorder mucopolysaccharidosis 7. Thursday, July 14, 2016 Another company had a setback in the quest to offer treatment to Duchenne muscular dystrophy patients. The FDA notified Santhera Pharmaceuticals that it would require the results from another trial, which is expected to take an additional three years. Friday, July 15, 2016 After two years of setbacks that saw it lose Big Pharma partners and its key drug flunk a trial, Ardelyx is now looking to raise a third of its market cap in a private placement. Thursday, July 14, 2016 Cell Medica buys Delenex, Celyad, Ono ink $300 million oncology deal and Horama bags cash for gene therapy trial. And more. Friday, July 15, 2016 Flagship Ventures welcomed Michael Rosenblatt, former Merck EVP and CMO, as its new CMO. Plus more hirings, firings and retirings throughout the industry. | | | Californian biotech Five Prime Therapeutics says GSK has exercised its option on a respiratory disease research collab, triggering a $1.5 million license payment to Five Prime. Statement Dr. Andreas Rummelt, the former CEO of Novartis’ biosims unit Sandoz, has been elected as a new supervisory board member at LEUKOCARE. Release CytRx has proposed a public offering of common stock and warrants worth $20 million just days after weak Phase III data for its key drug saw its shares crater. Statement TheStreet is reporting that a brain tumor patient has died after receiving a Ziopharm gene therapy injection. Story The U.K. health secretary Jeremy Hunt has kept his post in a Cabinet reshuffle initiated this week by the new British prime minister Theresa May. Story | |
|
Resources Sponsored by: SDC Interested in intended use validation of SaaS-based EDC systems? Prefer to discuss rescue study strategies and considerations? How about understanding statistical power for non-statisticians? Vote for your favorite webinar topic to be presented by SDC at DIA on June 28, 2016, 12pm EDT. Cast Your Vote Here to receive your exclusive event invitation and a recording of the webinar after the event. Sponsored by: Veeva Systems Gartner research on short- and long-term strategies for IDMP compliance. |
|
